PSPA’s 30th Anniversary Awards nomination period opens! Blog PSPA’s 30th Anniversary Awards nomination period opens! Nominations for the PSPA 30th Anniversary Awards are now open! The 30th Anniversary awards to…PSPA Admin30th January 2024
First participant dosed in the Amylyx trial BlogResearch First participant dosed in the Amylyx trial The first participant in the Amylyx stage three trial began receiving doses before Christmas! The…PSPA Admin23rd January 2024
Check out our Jubilee Tea Party Pack! CommunicationsFundraisingVolunteering Check out our Jubilee Tea Party Pack! Celebrate the Queen's Jubilee whilst raising awareness of PSP & CBD with a PSPA Jubilee…PSPA Admin6th May 2022
PSPA Funded Research Update CommunicationsInformation & SupportResearchVolunteering PSPA Funded Research Update Since the lockdown began, many medical researchers who also usually hold clinical posts such as…PSPA Admin20th May 2020
OxQuip – Oxford study of Quantification in Parkinsonism Research OxQuip – Oxford study of Quantification in Parkinsonism OxQuip are looking for patients with Progressive Supranuclear Palsy to participate in a research study.…PSPA Admin4th February 2020
Initial findings from the PROSPECT Study CommunicationsFundraisingInformation & SupportResearchVolunteering Initial findings from the PROSPECT Study Research estimates that up to 10,000 people may be living with PSP & CBD in…PSPA Admin20th December 2019
PASSPORT Study Discontinued CommunicationsResearch PASSPORT Study Discontinued At the end of last week pharmaceutical company Biogen announced they would be discontinuing their…PSPA Admin18th December 2019
25 years of PSPA – interview with our founder Michael Koe CommunicationsFundraisingInformation & SupportResearchVolunteering 25 years of PSPA – interview with our founder Michael Koe “We were so upset that no one seemed to know or care about PSP.” When…PSPA Admin5th April 2019